*Some Market data delayed by 15 mins.

Moderna, Inc. Common Stock

Symbol: MRNA (NASDAQ)
140.84 ▲ (5.97%) 7.936

Company Description:
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Key Stats
  • Today's Open: $132.98
  • Today's High: $142.703
  • Today's Low: $131.791
  • Today's Volume: 4.71M
  • Yesterday Close: $132.9
  • Yesterday High: $134.6
  • Yesterday Low: $129.67
  • Yesterday Volume: 2.68M
  • Last Min Volume: 0
  • Last Min High: $140.837
  • Last Min Low: $140.836
  • Last Min VWAP: $0
Company Profile
  • Name: Moderna, Inc. Common Stock
  • Website: https://www.modernatx.com
  • Listed Date: 2018-12-07
  • Location: CAMBRIDGE, MA
  • Market Status: Active
  • CIK Number: 0001682852
  • SIC Code: 2836
  • SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Market Cap: $54.04B
  • Round Lot: 100
  • Outstanding Shares: 383.24M
  • Asset Type: CS
RECENT FILINGS FOR MRNA
Filing DateFiling TypeFormat
2024-05-174View
2024-05-174View
2024-05-15144View
2024-05-15144View
2024-05-134View
2024-05-104View
2024-05-10144View
2024-05-098-KView
2024-05-08144View
2024-05-074View
2024-05-074View
2024-05-074View
2024-05-074View
2024-05-074View
2024-05-074View
2024-05-074View
2024-05-074View
2024-05-034View
2024-05-0210-QView
2024-05-028-KView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.